TAVR for Aortic Regurgitation in 2025: An ALIGN-AR and ARTIST Trial Update

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Consultant Fee/Honoraria/Speaker's Bureau - Magenta; Abbott Vascular; AriaCV
• CMO - JenaValve